Symbol
SNDX on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock
Latest Disclosed Ownership
5.95M shares
Security Ownership
7%
Shares, Excluding Options vs Price
Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in Syndax Pharmaceuticals Inc Common Stock (SNDX)

2025-02-12 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.95M shares of Syndax Pharmaceuticals Inc Common Stock (SNDX). This represents 7% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.